Evogene Ltd
EVGN
Market Cap$7.27M
Close$
Share Statistics
| Market cap | $7.27 Million |
|---|---|
| Enterprise Value | $5.53 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.89 |
| Beta | 1.29 |
| Outstanding Shares | 6,795,589 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.4 |
|---|---|
| PEG | 0.37 |
| Price to Sales | 1.09 |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.45 |
| Debt to Equity | -9.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Evogene Ltd
CEO: Ofer Haviv Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, I...